CellTrend diagnostic test

The CellTrend Diagnostic Test is a commercial ME/CFS diagnostic assay created by CellTrend and Professor Doctor Carmen Scheibenbogen. The test and its cost have been criticised by patients.

Auto-antibodies
Cell-Trend bases its test on the theory that a subset of 20-30% of all patients suffering from ME/CFS have developed elevated levels of three auto-antibodies, i.e., auto-antibodies against the b2-adrenergic receptor, auto-antibodies against the muscarinic cholinergic receptor 3 (M3) and auto-antibodies against the muscarinic cholinergic receptor 4 (M4).

Notable studies

 * 2016, Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome